Allarity Therapeutics, Inc. (ALLR) vs Karyopharm Therapeutics Inc. (KPTI)
A side-by-side comparison of Allarity Therapeutics, Inc. and Karyopharm Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ALLR
Allarity Therapeutics, Inc.
$0.99HealthcareDelayed quote: Oct 6, 2026, 1:20 PM EDT
KPTI
Karyopharm Therapeutics Inc.
$0.70HealthcareDelayed quote: Oct 6, 2026, 1:25 PM EDT
Total return — ALLR vs KPTI
growth of $100 · dividends reinvested · last 5yALLR -100.0% (-95.9%/yr)KPTI -99.3% (-62.9%/yr)KPTI compounded faster over this window
Log scale — wide-divergence pair
ALLR KPTI
ALLR vs KPTI: by the numbers
- •KPTI is the larger company ($16M vs $16M market cap).
- •Both run net losses; KPTI's is the smaller (-153.28% vs -3575.07% net margin).
Metrics side by side
Valuation
| Metric | ALLR | KPTI |
|---|---|---|
| P/S ratio | 45.54 | 0.11 |
| P/B ratio | 4.44 | N/A |
Profitability
| Metric | ALLR | KPTI |
|---|---|---|
| Gross margin | 107.54% | 95.88% |
| Operating margin | -3939.06% | -56.17% |
| Net margin | -3575.07% | -153.28% |
| ROE | -348.81% | N/A |
| ROIC | -41.81% | N/A |
Growth (annualized)
| Metric | ALLR | KPTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 7.47% |
| Total return CAGR (5Y) | N/A | -62.18% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.